( December 18, 2023, 2:33 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Dec. 18 agreed to dismiss an appeal of a final written decision (FWD) by the Patent Trial and Appeal Board that declared a method of producing nicotinamide riboside (NR) and compositions containing NR patent-ineligible....